Putrid compound may have a sweet side gig as atherosclerosis treatment

Atherosclerosis
Atherosclerosis is a condition affecting the cardiovascular system. If atherosclerosis occurs in the coronary arteries (which supply the heart) the result may be angina pectoris, or in worse cases a heart attack. Credit: Wikipedia/CC BY 3.0

Putrescine, the compound responsible for perhaps the foulest odor in nature—the smell of decomposing flesh—may also be a remedy for atherosclerosis and other chronic inflammatory diseases, according to a new study led by researchers at Columbia University Irving Medical Center.

This unusual discovery stems from an investigation into the body's process for removing dead using macrophages, a type of white blood cell that digests dead cells.

"It's estimated that a billion cells die in the body every day, and if you don't get rid of them, they can cause inflammation and tissue death," says Ira Tabas, MD, Ph.D., the Richard J. Stock Professor of Medicine and professor of pathology & (in physiology & cellular biophysics) at Columbia University Vagelos College of Physicians and Surgeons. "Removing these dead cells by a process called 'efferocytosis' (from the Latin 'to carry to the grave') is one of the body's most important functions."

Normally, the process is initiated within minutes of cell death. However, studies have suggested that this essential housekeeping task is impaired in atherosclerosis, promoting the accumulation of plaques.

To learn more, Tabas, Arif Yurdagul Jr, Ph.D., associate research scientist in the Tabas lab, and colleagues set up human macrophages and dying cells in a dish and watched how the process unfolded.

That's when they detected the role of putrescine. Macrophages, they found, reclaim arginine and other from the dead cells they engulf and use an enzyme to convert arginine into putrescine. Putrescine then activates a protein (Rac1) that signals the macrophages to eat more dead cells.

The results suggested atherosclerosis may be partly a putrescine problem, so the researchers turned to mice with atherosclerosis to investigate.

The researchers found that mice with worsening atherosclerosis had a short supply of putrescine because they didn't have enough of a key enzyme (arginase 1) to make the compound. "But when we put putrescine in the animals' drinking water, their macrophages got better at eating dead cells and the plaques improved."

The findings suggest that putrescine could be used to treat and other conditions characterized by , such as Alzheimer's.

But who would want to take a medicine that smells like rotting flesh?

"Fortunately, when you dissolve putrescine into water, at least at the dosages needed to improve the plaques, it no longer gives off its odor. The mice drank it without any problem and show no signs of sickness," says Tabas, whose findings were published online Jan. 30 in the journal Cell Metabolism.

"Of course we do not yet know the feasibility and safety of using low-dose putrescine to ward off atherosclerotic heart disease and other diseases driven by defective efferocytosis. However, the study shows the potential of treating heart disease with compounds that help macrophages eat and that are currently in for other indications."

The study is titled "Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury."


Explore further

Nanoparticle chomps away plaques that cause heart attacks

More information: "Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury," Cell Metabolism (2020). DOI: 10.1016/j.cmet.2020.01.001
Journal information: Cell Metabolism

Citation: Putrid compound may have a sweet side gig as atherosclerosis treatment (2020, January 30) retrieved 2 July 2020 from https://medicalxpress.com/news/2020-01-putrid-compound-sweet-side-gig.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
180 shares

Feedback to editors

User comments